# Hyperbaric Oxygen Therapy on Long COVID Symptoms: A Breath of Fresh Air

## TL;DR

This paper reviews how hyperbaric oxygen therapy may help alleviate long COVID symptoms like fatigue and cognitive issues.

## Contribution

The paper provides a literature analysis on the current state of HBOT as a potential treatment for long COVID.

## Key findings

- HBOT may improve quality of life, fatigue, cognition, and neuropsychiatric symptoms in long COVID patients.
- HBOT appears safe and shows potential benefits for cardiopulmonary functions and neurological disorders.
- Further large-scale studies are needed to define optimal HBOT protocols and indications.

## Abstract

Long COVID is defined as “the continuation or development of new symptoms 3 months after the initial SARS-CoV-2 infection, with these symptoms lasting for at least 2 months with no other explanations”, as reported by the World Health Organization. A growing number of people are dealing with a variety of lingering symptoms even after recovering from an acute infection. These can include fatigue, muscle pain, shortness of breath, headaches, cognitive issues, neurodegenerative symptoms, anxiety, depression, and a feeling of hopelessness, and therapeutic options for long COVID are investigated. The potential of hyperbaric oxygen therapy (HBOT) to improve chronic fatigue, cognitive impairments, and neurological disorders has been established; therefore, the use of HBOT to treat long COVID has also been studied. The aim of this literature search is to analyze the state of the art of a potential role of HBOT to improve chronic fatigue, cognitive impairments and neurological disorders. A literature analysis was performed, focusing on the clinical efficacy of HBOT for treating long COVID symptoms. The results from January 2021 to October 2025, using a standard registry database, showed 21 studies, including one case report, ten randomized controlled trial, eight systematic reviews and three studies regarding the molecular mechanism and markers changing after HBOT. They suggested that HBOT can improve quality of life, fatigue, cognition, neuropsychiatric symptoms and cardiopulmonary functions. HBOT is a safe treatment and has shown some benefits for long COVID symptoms. To precisely define indications, protocols, and post-treatment evaluations, we need to conduct more in-depth, large-scale studies.